SLN · Silence Therapeutics plc
$13.72
-0.25 (-1.79%)
At close · Aug 14
Market Cap
$1.94B
Shares
141.74M
Silence Therapeutics plc Earnings Call Transcripts
Every quarterly earnings call for Silence Therapeutics plc (SLN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-19
H.C. Wainwright BioConnect Investor Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY24 · Q4
2025-02-27
Silence Therapeutics plc Q4 FY2024 Earnings Call
Positive tone
Zerlasiran Phase 3 strategy and partnering
Divesiran in polycythemia vera
SLN548 complement factor B program
Revenue
$25.30M*
Gross margin
91.9%
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q4
2023-12-31
Silence Therapeutics plc Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q4
2022-12-31
Silence Therapeutics plc Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q4
2021-12-31
Silence Therapeutics plc Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q2
2021-08-12
Silence Therapeutics plc Q2 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Silence Therapeutics plc Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q2
2020-06-30
Silence Therapeutics plc Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–9 of 9 earnings calls
Key facts
CIK
1479615
CUSIP
82686Q101
13F (30d)
73 filings
72 filers
Visit website
Investor relations